CymaBay Therapeutics, Inc. 3 SEC Filings

Filed On	Filing
22 May 2023	Form 3: Shantharam Harish, Chief Financial Officer No securities owned
21 Mar 2022	Form 3: Lefebvre Eric, Director No securities owned
17 May 2021	Form 3: Kim Dennis D, Chief Medical Officer No securities owned
10 May 2021	Form 3: Stuart Lewis J, Chief Commercial Officer Holds 1,000 shares of Common Stock
05 Apr 2021	Form 3: Wiggans Thomas G, Director No securities owned
05 Apr 2021	Form 3: Dorling Janet, Director No securities owned
13 Oct 2020	Form 3: Quinlan Paul T, General Counsel No securities owned
05 Aug 2020	Form 3: Avoro Capital Advisors Llc, 10% owner and 1 other Holds 10,300,000 shares of Common Stock, par value $0.0001 per share
05 Aug 2019	Form 3: Dorling Janet, Chief Commercial Officer No securities owned
31 Jan 2019	Form 3: Dickinson Klara, Chief Regulatory Officer
04 Dec 2017	Form 3: Quinlan Paul T, General Counsel No securities owned
30 Jun 2017	Form 3: Dickinson Klara, SVP, Regulatory Affairs & QA No securities owned
05 May 2017	Form 3: Menold Daniel, Vice President, Finance
08 Dec 2016	Form 3: Booth Robert F., Director No securities owned
08 Dec 2016	Form 3: Loewy Caroline M, Director No securities owned
01 Apr 2016	Form 3: Truex Paul F, Director No securities owned
01 Apr 2016	Form 3: Stein Evan A., Director Holds 100,000 shares of Common Stock
01 Apr 2016	Form 3: Weiland Robert J., Director No securities owned
28 Jan 2016	Form 3: OMara Patrick J., VP, Business Development Holds 22 shares of Common Stock
01 May 2015	Form 3: Rosemark Kirk, V.P. Regulatory & Quality No securities owned

Comments